Literature DB >> 33448885

Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country.

Jayastu Senapati1, Rishi Dhawan1, Mukul Aggarwal1, Pradeep Kumar1, Ganesh Kumar Vishwanathan1, Jasmita Dass1, Seema Tyagi1, Manoranjan Mahapatra1, Tulika Seth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33448885     DOI： 10.1080/10428194.2020.1867724

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  [Short-term efficacy of venetoclax combined with azacitidine in acute myeloid leukemia: a single-institution experience].

Authors:  W J Yu; J S Jia; J Wang; F F Tang; L Z Gong; X H Liu; X L Zhu; X S Zhao; X J Huang; H Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.